Related Experiment Video
Updated: Mar 20, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Screening, Characterization, and Mode of Action of Three Lactic Acid Bacteria Against Helicobacter pylori
Ziqi Wei1, Zhen Peng2,3, Junyi Li1
1State Key Laboratory of Food Science and Resources, Nanchang University, 235 Nanjing East Road, Nanchang, 330047, Jiangxi Province, China.
Abstract:
Helicobacter pylori (H. pylori) is the leading cause of infectious gastritis, and its resistance to antibiotics is becoming increasingly significant. Probiotics have been widely reported to have antagonistic effects on H. pylori. In this study, 52 strains of lactic acid bacteria (LAB) were isolated from the feces of healthy human and animal. The acid tolerance, anti-H. pylori ability, urease inhibition rate, and nickel adsorption rate of 19 LAB were determined. PCA evaluation revealed Lactiplantibacillus plantarum (L. plantarum) NCUA001057, Pediococcus pentosaceus (P. pentosaceus) NCUH006018, and L. plantarum NCUH001090 displaying the best comprehensive performance. Subsequently, the hemolytic, bile salt tolerance, antioxidant capacity, co-aggregation ability with H. pylori, and adhesion rate to AGS cells of three LAB were evaluated. Moreover, three LAB downregulated the production of IL-1β and IL-8 in H. pylori pre-treated AGS cells. We preliminarily studied the antibacterial substances of three LAB which mainly included acid, hydrogen peroxide, and protein, and the antibacterial substances are heat-tolerant. Furthermore, we found that the main modes of antibacterial action of P. pentosaceus NCUH006018 were as follows: inhibited the adhesion of H. pylori to AGS cells, made H. pylori spherical and destroyed its intact cell structure, and downregulated the metabolism genes of H. pylori flagellin and ribosome. In this study, the high potential of antagonizing H. pylori by three novel LAB was demonstrated, and their mode of antibacterial action provided a new strategy for prevention or inhibition of H. pylori infection.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Microbiota of the Stomach and Small Intestine
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Probiotics
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

